Research Nester released a report titled “Anti-Counterfeit Pharmaceutical Packaging Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the global anti-counterfeit pharmaceutical packaging market in terms of market segmentation by technology, application and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The anti-counterfeit pharmaceutical packaging market is expected to garner a sizeable revenue and record a significant CAGR over the forecast period, i.e., 2021 – 2029, owing to the increasing incidences of counterfeit medicines, advancement in technology of drug packaging, and the rising demand to counter the sale of fake pharmaceutical products.
The market is segmented by technology and feature. On the basis of technology, the segment for mass encoding is predicted to gather the largest share during the forecast period, which can be attributed to its excellent product tracking solution through the multiple nodes in the logistics and supply chain. However, the RFID segment is projected to record the highest growth rate on account of better product security and tracking characteristics of this technology.
Geographically, the anti-counterfeit pharmaceutical packaging market is segmented into five major regions, including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. North America is predicted to account for the largest share in the market on the back of strong presence of major key players in the region. Furthermore, Asia Pacific’s market is evaluated to witness highest CAGR during the forecast period ascribing to the consumer awareness about what they are buying before consumption.
Stringent Government Policies Associated with Counterfeiting of Drugs to Drive Market Growth
A crucial factor for the growth of the market is the strict governmental regulations in various countries regarding circulation of counterfeit medicines that causes the key players to invest more money on good anti-counterfeit technologies. This has led to the arrival of unique edible micro tags for the classification, authentication, brand protection, and quality assurance of medicines.
However, expensive setup of anti-counterfeit packaging systems is expected to operate as key restraint in the growth of global anti-counterfeit pharmaceutical packaging market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global anti-counterfeit pharmaceuticals packaging market which includes company profiling of Avery Dennison Corporation (NYSE: AVY), CCL Industries Inc. (TSE: CCL.B), DuPont de Nemours, Inc. (NYSE: DD), AlpVision S.A, SICPA HOLDING SA, Applied DNA Sciences Inc. (NASDAQ: APDN), ATL Corp, Alien Technology, LLC., Authentix, Inc., Impinj, Inc (NASDAQ: PI), and others.
The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the anti-counterfeit pharmaceutical packaging market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
U.S. Phone: [+1 646 586 9123]
U.K. Phone: [+44 203 608 591]